Solid Biosciences Inc. SLDB Internal General And Administrative Expense — General And Administrative Expense
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense?
- Solid Biosciences Inc. (SLDB) reported internal general and administrative expense — general and administrative expense of $3.87M in Q1 2026.
- How has Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense changed year-over-year?
- Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense increased by 11.6% year-over-year, from $3.46M to $3.87M.
- What is the long-term trend for Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense?
- Over 2 years (2023 to 2025), Solid Biosciences Inc.'s internal general and administrative expense — general and administrative expense has grown at a 13.1% compound annual growth rate (CAGR), from $10.91M to $13.96M.
- What does internal general and administrative expense — general and administrative expense mean?
- This metric represents the operating costs incurred by the company to support its internal administrative functions, such as executive management, legal, finance, and human resources. It reflects the overhead required to sustain corporate operations and infrastructure independent of direct research and development activities. Monitoring this expense helps investors evaluate the company's operational efficiency and the scalability of its corporate support structure.